REG - Anemoi International - Admission to Trading on the London Stock Exchange

Anemoi InternationalAnnouncement

17/12/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211217:nRSQ9619Va&default-theme=true

RNS Number : 9619V  Anemoi International Ltd  17 December 2021

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO
THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, ANY
MEMBER STATE OF THE EEA (OTHER THAN THE UNITED KINGDOM) OR ANY OTHER
JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS
OF THAT JURISDICTION

 

17 December 2021

 

Anemoi International Ltd

("Anemoi" or the "Company")

 

Admission to Trading on the London Stock Exchange

Anemoi International Ltd (LSE:AMOI), is pleased to announce that following the
publication of its Prospectus on 13 December 2021, 157,041,665 ordinary shares
of $0.001 each will be admitted to the Standard Segment of the Official List
of the Financial Conduct Authority and to trading on the London Stock
Exchange's Main Market at 8.00 a.m. GMT today under the ticker "AMOI"
("Admission"). The ISIN is VGG0419A1057‎.

Upon Admission:

·     the id4 AG acquisition will become unconditional;

·     66,666,666 New Ordinary Shares will be issued to the shareholders
of id4;

·     54,375,000 New Ordinary Shares will be issued to placees in the
Placing; and

·     the appointment of Rémy‎ Schimmel and Tim Donell to the
Company's board will become effective.

Duncan Soukup, Executive Chairman, commented:

"We are delighted to announce the closing of the id4 AG acquisition and
welcome Rémy‎ Schimmel and Tim Donell to the Anemoi Board."

Since the publication of a prospectus by the Company on 13 December 2021, id4
AG has continued to trade in line with management expectations.

The Company's issued share capital is 157,041,665 Ordinary Shares. This figure
may be used by shareowners as the denominator for the calculations by which
they will determine whether they are required to notify their interests in, or
a change to their interest in, the Company under the Financial Conduct
Authority's Disclosure Guidance and Transparency Rules.

This Announcement should be read in its entirety. In particular, you should
read and understand the information provided in the "Important Notices"
section below.

Terms used in this announcement shall, unless the context otherwise requires,
be as defined in the ‎announcement published by the Company on 13 December
2021 in relation to the Acquisition of id4 AG ‎and the Placing‎.‎

 

 Anemoi International Ltd

 Duncan Soukup             +33 676 84 50 51

 Remy Schimmel             +41 79 513 87 38

 Peterhouse (Broker)       +44 207 220 9791

 Charles Goodfellow

 Yellow Jersey PR          anemoi@yellowjerseypr.com (mailto:anemoi@yellowjerseypr.com)

 Charles Goodwin           +44 7747 788 221

 Tom Randell

 Matthew McHale

 LEI: 213800MIKNEVN81JIR76 ‎

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) No 596/2014 ("MAR") as it forms part of UK
domestic law by virtue of the European Union (Withdrawal) Act 2018, as
amended.  Upon the publication of this announcement via Regulatory
Information Service, this inside information is now considered to be in the
public domain.

 

DISCLAIMER

 

Peterhouse, which is authorised and regulated in the United Kingdom by the
Financial Conduct Authority, is acting as broker to the Company in relation to
the Placing. Persons receiving this announcement should note that Peterhouse
will not be responsible to anyone other than the Company for providing the
protections afforded to its clients or for advising any other person on the
arrangements described in this announcement. Peterhouse has not authorised the
contents of, or any part of, this announcement and no liability whatsoever is
accepted by it for the accuracy of any information or opinion contained in
this announcement or for the omission of any information.

 

IMPORTANT NOTICES

 

This announcement includes statements that are, or may be deemed to be,
"forward-looking statements". These forward-looking statements can be
identified by the use of forward-looking terminology, including the terms
"believes", "estimates", "plans", "anticipates", "targets", "aims",
"continues", "expects", "intends", "hopes", "may", "will", "would", "could" or
"should" or, in each case, their negative or other variations or comparable
terminology. These forward-looking statements include matters that are not
facts. They appear in a number of places throughout this announcement and
include statements regarding the Directors' beliefs or current expectations
concerning, amongst other things, the amount of capital which will be returned
by the Company and the taxation of such amounts in the hands of Shareholders.
By their nature, forward-looking statements involve risk and uncertainty
because they relate to future events and circumstances. Investors should not
place undue reliance on forward-looking statements, which speak only as of the
date of this announcement.

 

The information given in this announcement and the forward-looking statements
speak only as at the date of this announcement. The Company, Peterhouse and
their respective affiliates expressly disclaim any obligation or undertaking
to update, review or revise any forward-looking statement contained in this
announcement to reflect actual results or any change in the assumptions,
conditions or circumstances on which any such statements are based unless
required to do so by the Financial Services and Markets Act 2000, the Listing
Rules, the Prospectus Regulation Rules or other applicable laws, regulations
or rules.

 

The Existing Ordinary Shares and the New Ordinary Shares have not, nor will
they be, registered under the US Securities Act of 1933, as amended (the "US
Securities Act") or with any securities regulatory authority of any state or
other jurisdiction of the United States or under the applicable securities
laws of Australia, Canada, Japan or the Republic of South Africa. The Existing
Ordinary Shares and the New Ordinary Shares to be issued by the Company may
not be offered or sold directly or indirectly in or into the United States
unless registered under the US Securities Act or offered in a transaction
exempt from or not subject to the registration requirements of the US
Securities Act or subject to certain exceptions, into Australia, Canada, Japan
or the Republic of South Africa or to, or for the account or benefit of, any
national, resident or citizen of Australia, Canada, Japan or the Republic of
South Africa. The Company has not been, and will not be, registered under the
US Investment Company Act of 1940, as amended.

 

The distribution of this announcement may be restricted by law in certain
jurisdictions and persons into whose possession any document or other
information referred to herein comes should inform themselves about and
observe any such restriction. Any failure to comply with these restrictions
may constitute a violation of the securities laws of any such jurisdiction.

 

The value of shares and the income from them is not guaranteed and can fall as
well as rise due to stock market and currency movements. When you sell your
investment you may get back less than you originally invested. All of the
value of an investor's investment in the Company will be at risk. Past
performance is not a guide to future performance and the information in this
circular or any documents relating to the matters described in it cannot be
relied upon as a guide to future performance. Persons needing advice should
contact a professional adviser.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  LISEAPAKFSNFFFA